WHO Endorses Single‑Dose RSV Vaccine for Over‑60s After Two‑Year Trial Shows 78% Efficacy
**WHO Endorses Single‑Dose RSV Vaccine for Over‑60s After Two‑Year Trial Shows 78% Efficacy** The World Health Organization has endorsed a…
**WHO Endorses Single‑Dose RSV Vaccine for Over‑60s After Two‑Year Trial Shows 78% Efficacy** The World Health Organization has endorsed a…